Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
מצבים רפואיים
Estrogen Receptor Negative · HER2 Positive Breast Carcinoma · HER2/Neu Negative · Invasive Breast Carcinoma · Progesterone Receptor Negative · Stage I Breast Cancer AJCC v7 · Stage IA Breast Cancer AJCC v7 · Stage IB Breast Cancer AJCC v7 · Stage II Breast Cancer AJCC v6 and v7 · Stage IIA Breast Cancer AJCC v6 and v7 · Stage IIB Breast Cancer AJCC v6 and v7 · Triple-Negative Breast Carcinoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
MD Anderson Cancer Center - Banner, Gilbert, Arizona, United States
Baptist MD Anderson Cancer Center, Jacksonville, Florida, United States
Contact: Principal Investigator (Beth A. Lesnikoski)Queen's Medical Center, Honolulu, Hawaii, United States
Mayo Clinic, Rochester, Minnesota, United States
Contact: Principal Investigator (Judy C. Boughey)Cooper Hospital Univ Med Ctr, MD Anderson at Cooper Voorhees, Voorhees Township, New Jersey, United States
Contact: Study coordinator (Catherine E. Loveland-Jones) · loveland-jones-catherine@CooperHealth.edu · 856-135-6207Contact: Principal Investigator (Catherine E. Loveland-Jones)Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States
Contact: Principal Investigator (Richard L. White)University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Emilia J. Diego)M D Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Henry M. Kuerer)
מובילי המחקר
Henry M Kuerer
Principal Investigator
M.D. Anderson Cancer Center